Literature DB >> 180773

Effects of brain gangliosides on functional recovery in experimental regeneration and reinnervation.

B Ceccarelli, F Aporti, M Finesso.   

Abstract

The effect of brain cortex gangliosides has been tested in two different experimental models of peripheral sympathetic regeneration and reinnervation: a) the preganglionic trunks of the cervical sympathetic nerve were joined in an end-to-end anastomosis after severing the preganglionic trunk, caudally to the superior cervical ganglion; this reinnervation is mainly of cholinergic type. b) the postganglionic trunks of the superior cervical ganglion were joined in an end-to-end anastomosis after severing the postganglionic trunk; this reinnervation is mainly of adrenergic type. Functional recovery following the regeneration and reinnervation has been evaluated by measuring tha contraction of the nictitating membrane, evoked by electrical stimulation of the sympathetic trunk caudally to the point of anastomosis. Some of the operated animals were daily treated with 50mg/kg i.p. of brain cortex gangliosides during the entire post-operative period. Forty-five, sixty days after the operation we observed in the treated animals of both experimental sets a relevant increase in the functional recovery (between 30 and 100%) compared to the operated but untreated controls. In the case of postganglionic anastomosis the physio-pharmacological studies were substantiated by the histochemical fluorescence observations of the distributions of catecholamines in the smooth muscle of the nictitating membranes. These results strongly suggest that the treatment with gangliosides greatly influences the regeneration and reinnervation process of both cholinergic and adrenergic nerve fibers.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180773     DOI: 10.1007/978-1-4614-4614-9_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Enhanced sprouting of retinotectal fibers after early superior colliculus lesions in hamsters treated with gangliosides.

Authors:  B A Sabel; G E Schneider
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

2.  Ultrastructural study of effect of ACTH4-10 on nerve regeneration; axons become larger in number and smaller in diameter.

Authors:  W A Bijlsma; E van Asselt; H Veldman; F G Jennekens; P Schotman; W H Gispen
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

3.  The Therapeutic Role of Gangliosides in Neurological Disorders.

Authors:  J S Schneider
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

4.  LIGA20, a lyso derivative of ganglioside GM1, given orally after cortical thrombosis reduces infarct size and associated cognition deficit.

Authors:  A Kharlamov; I Zivkovic; A Polo; D M Armstrong; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

5.  Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies.

Authors:  M Schwartz; N Spirman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Monosialoganglioside (GM1) treatment of ouabain-induced retinopathy in the rabbit.

Authors:  F Norido; R Canella; R Zanoni; A Gorio
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 7.  Gangliosides. Their role in clinical neurology.

Authors:  E Nobile-Orazio; M Carpo; G Scarlato
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 8.  Ganglioside function in the development and repair of the nervous system. From basic science to clinical application.

Authors:  S D Skaper; A Leon; G Toffano
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

Review 9.  GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.

Authors:  Elena Chiricozzi; Giulia Lunghi; Erika Di Biase; Maria Fazzari; Sandro Sonnino; Laura Mauri
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

Review 10.  Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition.

Authors:  Maria Fazzari; Giulia Lunghi; Elena Chiricozzi; Laura Mauri; Sandro Sonnino
Journal:  Biomedicines       Date:  2022-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.